In this study, we found that BAG2 was significantly up-regulated in HCC, and patients with high expression of BAG2 showed a significantly shorter overall survival (OS), progression free survival (PFS) and disease specific survival (DSS). This evidence concerns the gene BAG2 and hepatocellular carcinoma.